Expression of serotonergic receptors in psoriatic skin

Archives of Dermatological Research

Volumn 298, Issue 3, 2006, Pages 99-106

  Nordlind, Klas ^a,b   Thorslund, Kristoffer ^a   Lonne Rahm, Solbritt ^a   Mohabbati, Sheila ^b   Berki, Timea ^c   Morales, Marisela ^d   Azmitia, Efrain C ^e  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF PÉCS   (Hungary)

^d NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^e NEW YORK UNIVERSITY   (United States)

Author keywords

Psoriasis; Receptors; Serotonin

Indexed keywords

SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 3 RECEPTOR; SEROTONIN RECEPTOR;

ADULT; AGED; ARTICLE; BASAL CELL; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDERMIS; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MELANOCYTE; MONONUCLEAR CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PSORIASIS;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; MALE; MICE; MIDDLE AGED; PSORIASIS; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTOR, SEROTONIN, 5-HT2A;

EID: 33748424565     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-006-0652-6     Document Type: Article

References (38)

1. Abdouh M, Albert PR, Drobetsky E, Filep JG, Kouassi E (2004) 5-HT1A-mediated promotion of mitogen-activated T and B cell survival and proliferation is associated with increased translocation of NF-kB to the nucleus. Brain Behav Immunol 18:24-34
2. Ackermann L, Harvima IT, Pelkonen J, Ritamäki-Salo V, Naukkarinen A, Harvima RJ, Horsmanheimo M (1999) Mast cells in psoriatic skin are strongly positive for interferon-gamma. Br J Dermatol 140:624-633
3. Ahlemeyer B, Glaser A, Schaper C, Semkova I, Krieglstein J (1999) The 5-HT1A receptor agonist Bay x3702 inhibits apoptosis induced by serum deprivation in cultured neurons. Eur J Pharmacol 370:211-216
4. Ameisen JC, Meade R, Askenase PW (1989) A new interpretation of the involvement of serotonin in delayed-type hypersensitivity. Serotonin-2 receptor antagonists inhibit contact sensitivity by an effect on T cells. J Immunol 142:3171-3179
5. Azmitia EC, McEwen BS (1969) Corticosterone regulation of tryptophan hydroxylase in midbrain of the rat. Science 166:1274-1276
6. Azmitia EC, Yu I, Akbari HM, Kheck N, Whitaker-Azmitia PM, Marshak DR (1992) Antipeptide antibodies against the 5-HT1A receptor. J Chem Neuroanat 15:289-298
7. Azmitia EC, Liao B, Chen Y (1993) Increase of tryptophan hydroxylase enzyme protein by dexamethasone in adrenalectomized rat midbrain. J Neurosci 13:5041-5055
8. Azmitia EC (1999) Serotonin neurons, neuroplasticity, and homeostasis of neural tissue. Neuropsychopharmacology 21(suppl. 2):S33-S45
9. Azmitia EC (2002) Modern views on an ancient chemical: serotonin effects on cell proliferation, maturation and apoptosis. Brain Res Bull 56:413-424
10. Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38:1083-1152
11. Barth JH, Baker H (1986) Generalized pustular psoriasis precipitated by trazodone in the treatment of depression. Br J Dermatol 115:629-630
12. Betten A, Dahlgren C, Hermodsson S, Hellstrand K (2001) Serotonin protects NK cells against oxidatively induced functional inhibition and apoptosis. J Leukoc Biol 70:65-72
13. 2A serotonin receptor and microtubule-associated protein MAP1A in cortical dendrites of adult rat. Neuroscience 113:23-35
14. DeFelipe J, Arellano JI, Gómez A, Azmitia EC, Munoz A (2001) Pyramidal cell axons show a local specialization for GABA and 5-HT inputs in monkey and human cerebral cortex. J Comp Neurol 433:148-155
15. Eastwood SL, Burnet PWJ, Gittins R, Baker K, Harrison PJ (2001) Expression of serotonin 5-HT2A receptors in the human cerebellum and alterations in schizophrenia. Synapse 42:104-114
16. 7. J Med Chem 46:2795-2812
17. Griffiths CEM, Richards HL (2001) Psychological influences in psoriasis. Clin Exp Dermatol 26:338-342
18. Hogg S, Dalvi A (2004) Acceleration of onset of action in schedule-induced polydipsia: combinations of SSRI and 5-HT1A and 5-HT1B receptor antagonists. Pharm Biochem Behav 77:69-75
19. Iyengar B (1998) The UV-responsive melanocyte system: a peripheral network for photoperiodic time measurements. A function of indoleamine expression. Acta Anat 163:173-178
20. Jiang WY, Chattedee AD, Raychaudhuri SP, Raychaudhuri SK (2001)Mast cell density and IL-8 expression in nonlesional and lesional psoriatic skin. Int J Dermatol 40:699-703
21. Johansson O, Liu PY, Bondesson L, Nordlind K, Olsson MJ, Lontz W, Verhofstad A, Liang Y, Gangi S (1998) A serotonin-like immunoreactivity is present in human cutaneous melanocytes. J Invest Dermatol 111:1010-1014
22. Kema IP, de Vries EGE, Muskiet FAJ (2000) Clinical chemistry of serotonin and metabolites. J Chromatogr B 747:33-48
23. Lundeberg L, Liang Y, Sundström E, Nordlind K, Verhofstad A, Lidén S, Johansson O (1999) Serotonin in human allergic contact dermatitis. An immunohistochemical and high performance liquid chromatography study. Arch Dermatol Res 291:269-274
24. Lundeberg L, El-Nour H, Mohabbati S, Morales M, Azmitia E, Nordlind K (2002) Expression of serotonin receptors in allergic contact eczematous human skin. Arch Dermatol 294:393-398
25. Maurer M, Opitz M, Henz BM, Paus R (1997) The mast cell products histamine and serotonin stimulate and TNF-alpha inhibits the proliferation of murine epidermal keratinocytes in situ. J Dermatol Sci 16:79-84
26. McAloon MB, Chandrasekar A, Lin Y-J, Hwang GC, Shaarpe RJ (1995) Buspirone inhibits contact hypersensitivity in the mouse. Int Arch Allergy Appl Immunol 107:437-438
27. Moiseiwitsch JR, Lauder JM (1995) Serotonin regulates mouse neural crest migration. Proc Natl Acad Sci USA 92:7182-7186
28. Morales M, Battenberg E, de Lecea L, Sanna PP, Bloom FE (1996) Cellular and subcellular immunolocalization of the type 3 serotonin receptor in the rat central nervous system. Brain Res Mol Brain Res 36:251-260
29. Nishi M, Azmitia EC (1999) Agonist- and antagonist-induced plasticity of rat 5-HT1A receptor in hippocampal cell culture. Synapse 31:186-195
30. Osborne SF, Stafford L, Orr KG (2002) Paroxetine-associated psoriasis. Am J Psychiatry 159:2113
31. Ozdamar SO, Seckin D, Kandemir B, Turanli AY (1996) Mast cells in psoriasis. Dermatology 192:190
32. Peters BP, Weissman FG, Gill MA(2000) Pathophysiology and treatment of psoriasis. Am J Health Syst Pharm 57:645-659
33. Pierce PA, Xie GX, Peroutka SJ, Green PG, Levine JD (1995) 5-Hydroxytryptamine-induced synovial plasma extravasation is mediated via 5-hydroxytryptamine2A receptors on sympathetic efferent terminals. J Pharmacol Exp Ther 275:502-508
34. Raymond JR, Mukhin YV, Gettys TW, Garnovskaya MN (1999) The recombinant 5-HT1AR receptor: G protein coupling and signalling pathways. Br J Pharmacol 127:1751-1764
35. Suchanek B, Struppeck H, Fahrig T (1998) The 5-HT1A receptor agonist BAYx3702 prevents staurosporine-induced apoptosis. Eur J Pharmacol 355:95-101
36. Verge D, Calas A (2000) Serotonergic neurons and serotonin receptors: gains from cytochemical approaches. J Chem Neuroanat 18:41-56
37. Wu C, Yoder EJ, Shih J, Chen K, Dias P, Shi L, Ji XD, Wei J, Conner JM, Kumar S, Ellisman MH, Singh SK (1998) Development and characterization of monoclonal antibodies specific to the serotonin 5-HT2A receptor. J Histochem Cytochem 46:811-824
38. Wu C, Singh SK, Dias P, Kumar S, Mann DMA (1999) Activated astrocytes display increased 5-HT2a receptor expression in pathological states. Exp Neurol 158:529-533